Article
Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.
Scientific reports - 5 Sept 2024
Delgado-Wicke Pablo, Fernández de Córdoba-Oñate Sara, Roy-Vallejo Emilia, Alegría-Carrasco Estíbaliz, Rodríguez-Serrano Diego A, Lamana Amalia, Montes Nuria, Nicolao-Gómez Ana, Carracedo-Rodríguez Rosa, Marcos-Jiménez Ana, Díaz-Fernández Paula, Galván-Román José M, Rabes-Rodríguez Laura, Sanz-Alba Marta, Álvarez-Rodríguez Jesús, Villa-Martí Almudena, Rodríguez-Franco Carlos, Villapalos-García Gonzalo, Zubiaur Pablo, Abad-Santos Francisco, de Los Santos Ignacio, Gomariz Rosa P, García-Vicuña Rosario, Muñoz-Calleja Cecilia, González-Álvaro Isidoro, Fernández-Ruiz Elena
Abstract excerpt
The characteristics of the host are crucial in the final outcome of COVID-19. Herein, the influence of genetic and clinical variants in COVID-19 severity was investigated in a total of 1350 patients. Twenty-one single nucleotide polymorphisms of genes involved in SARS-CoV-2 sensing as Toll-like-Receptor 7, antiviral immunity as the type I interferon signalling pathway (TYK2, STAT1, STAT4, OAS1, SOCS) and the...
Topics
- Humans
- COVID-19
- Male
- Female
- Polymorphism, Single Nucleotide
- Middle Aged
- Severity of Illness Index
